Space Seed Holdings and Gifu University Identify Eight Seaweed Compounds for Follow-Up Testing Using Spaceflight Gene-Expression Data

Space Seed Holdings and Gifu University have utilized generative AI to cross-reference public databases and identify eight seaweed compounds for potential spaceflight-related health research. The study aims to prioritize compounds for future testing, though researchers emphasize that the findings are exploratory and do not yet prove safety or efficacy.
Why it matters
This demonstrates a novel application of generative AI in bioinformatics to accelerate drug discovery and cross-reference disparate scientific datasets.
Space Seed Holdings Inc. (“SSHD”) and Gifu University used three public databases to identify eight compounds reported in seaweeds and compare their gene-expression profiles with changes observed in human blood before and after spaceflight. The analysis counted genes whose expression changed in opposite directions across the two datasets, to help prioritize compounds for follow-up experiments. Generative AI assisted with data matching and construction of the analysis pipeline.
The results are exploratory and are intended to set priorities for experiments. The comparison uses separate datasets from astronauts’ blood and compound-treated cell lines, so it does not show that any compound reversed a spaceflight change. Nor does it show that any compound is effective or safe in humans, or that it can be added to foods.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in